Patient Selection for Bronchoscopic Lung Volume Reduction

References

• HerthFJF, SlebosD-J, CrinerGJ, ValipourA, SciurbaF, ShahPL. Endoscopic lung volume reduction: an expert panel recommendation - update 2019. Respiration. 2019;1–10. doi:10.1159/000496122
   Web of Science ®Google Scholar
• van GeffenWH, SlebosD-J, HerthFJ, S VK, WederW, ShahPL. Surgical and endoscopic interventions that reduce lung volume for emphysema: a systemic review and meta-analysis. Lancet Respir Med. 2019;7(4):313–324. doi:10.1016/S2213-2600(18)30431-430744937
   PubMed Web of Science ®Google Scholar
• KloosterK, Ten HackenNHT, HartmanJE, KerstjensHAM, van RikxoortEM, SlebosD-J. endobronchial valves for emphysema without interlobar collateral ventilation. N Engl J Med. 2015;373(24):2325–2335. doi:10.1056/NEJMoa150780726650153
   PubMed Web of Science ®Google Scholar
• ValipourA, HerthFJF, BurghuberOC, et al. Target lobe volume reduction and COPD outcome measures after endobronchial valve therapy. Eur Respir J. 2014;43(2):387–396. doi:10.1183/09031936.0013301223845721
   PubMed Web of Science ®Google Scholar
• KosterTD, van RikxoortEM, HuebnerR-H, et al. Predicting lung volume reduction after endobronchial valve therapy is maximized using a combination of diagnostic tools. Respiration. 2016;92(3):150–157. doi:10.1159/00044884927577190
   PubMed Web of Science ®Google Scholar
• DaveyC, ZoumotZ, JordanS, et al. Bronchoscopic lung volume reduction with endobronchial valves for patients with heterogeneous emphysema and intact interlobar fissures (the BeLieVeR-HIFi study): a randomised controlled trial. Lancet. 2015;386(9998):1066–1073. doi:10.1016/S0140-6736(15)60001-026116485
   PubMed Web of Science ®Google Scholar
• SlebosD-J, CiceniaJ, SciurbaFC, et al. Predictors of response to endobronchial coil therapy in patients with advanced emphysema. Chest. 2019;155(5):928–937. doi:10.1016/j.chest.2019.02.01230797746
   PubMed Web of Science ®Google Scholar
• HerthFJF, EberhardtR, GompelmannD, et al. Radiological and clinical outcomes of using ChartisTM to plan endobronchial valve treatment. Eur Respir J. 2013;41(2):302–308. doi:10.1183/09031936.0001531222556025
   PubMed Web of Science ®Google Scholar
• ValipourA, SlebosD-J, HerthF, et al. Endobronchial valve therapy in patients with homogeneous emphysema. Results from the IMPACT Study. Am J Respir Crit Care Med. 2016;194(9):1073–1082. doi:10.1164/rccm.201607-1383OC27580428
   PubMed Web of Science ®Google Scholar
• KempSV, SlebosD-J, KirkA, et al. A multicenter randomized controlled trial of zephyr endobronchial valve treatment in heterogeneous emphysema (TRANSFORM). Am J Respir Crit Care Med. 2017;196(12):1535–1543. doi:10.1164/rccm.201707-1327OC28885054
   PubMed Web of Science ®Google Scholar
• CrinerGJ, SueR, WrightS, et al. A multicenter randomized controlled trial of zephyr endobronchial valve treatment in heterogeneous emphysema (LIBERATE). Am J Respir Crit Care Med. 2018;198(9):1151–1164. doi:10.1164/rccm.201803-0590OC29787288
   PubMed Web of Science ®Google Scholar
• SciurbaFC, CrinerGJ, StrangeC, et al. Effect of endobronchial coils vs usual care on exercise tolerance in patients with severe emphysema: the RENEW randomized clinical trial. JAMA. 2016;315(20):2178–2189. doi:10.1001/jama.2016.626127179849
   PubMed Web of Science ®Google Scholar
• SlebosD-J, KloosterK, ErnstA, HerthFJF, KerstjensHAM. Bronchoscopic lung volume reduction coil treatment of patients with severe heterogeneous emphysema. Chest. 2012;142(3):574–582. doi:10.1378/chest.11-073022116796
   PubMed Web of Science ®Google Scholar
• DesleeG, KloosterK, HetzelM, et al. Lung volume reduction coil treatment for patients with severe emphysema: a European multicentre trial. Thorax. 2014;69(11):980–986. doi:10.1136/thoraxjnl-2014-20522124891327
   PubMed Web of Science ®Google Scholar
• KloosterK, Ten HackenNHT, FranzI, KerstjensHAM, van RikxoortEM, SlebosD-J. Lung volume reduction coil treatment in chronic obstructive pulmonary disease patients with homogeneous emphysema: a prospective feasibility trial. Respiration. 2014;88(2):116–125. doi:10.1159/00036252224902999
   PubMed Web of Science ®Google Scholar
• ComeCE, KramerMR, DransfieldMT, et al. A randomised trial of lung sealant versus medical therapy for advanced emphysema. Eur Respir J. 2015;46(3):651–662. doi:10.1183/09031936.0020561425837041
   PubMed Web of Science ®Google Scholar
• SlebosD-J, KloosterK, ErasmusM. Emphysema! Am J Respir Crit Care Med. 2012;186(2):197. doi:10.1164/rccm.201201-0067IM22798416
   PubMed Web of Science ®Google Scholar
• SnellGI, HolsworthL, KhorramniaS, et al. Feasibility and safety of a transthoracic pneumostoma airway bypass in severe emphysema patients. Respiration. 2017;93(4):236–246. doi:10.1159/00045587828142136
   PubMed Web of Science ®Google Scholar
• SlebosD-J, ShahPL. Collateral ventilation: friend or foe in patients with severe emphysema. Respiration. 2017;93(4):232–233. doi:10.1159/00045667228122373
   PubMed Web of Science ®Google Scholar
• ShahP, SlebosD-J, CardosoP, et al. Bronchoscopic lung-volume reduction with Exhale airway stents for emphysema (EASE trial): randomised, sham-controlled, multicentre trial. Lancet. 2011;378(9795):997–1005. doi:10.1016/S0140-6736(11)61050-721907863
   PubMed Web of Science ®Google Scholar
• National Emphysema Treatment Trial Research Group, FishmanA, FesslerH, et al. Patients at high risk of death after lung-volume–reduction surgery. N Engl J Med. 2001;345(15):1075–1083. doi:10.1056/NEJMoa11798.11596586
   PubMed Web of Science ®Google Scholar
• LikertR. A technique for the measurement of attitudes. Arch Psychol. 1932;22(140):55.
   Google Scholar
• PolkeM, RöttingM, SarmandN, et al. Interventional therapy in patients with severe emphysema: evaluation of contraindications and their incidence. Ther Adv Respir Dis. 2019;13:175346661983549. doi:10.1177/1753466619835494
   Web of Science ®Google Scholar
• SlebosD-J, BreenD, CoadJ, et al. safety and histological effect of liquid nitrogen metered spray cryotherapy in the lung. Am J Respir Crit Care Med. 2017;196(10):1351–1352. doi:10.1164/rccm.201611-2220LE28358989
   PubMed Web of Science ®Google Scholar
• SlebosD-J, ShahPL, HerthFJ, et al. Safety and adverse events after targeted lung denervation for symptomatic moderate to severe COPD (AIRFLOW): a multicenter randomized controlled trial. Am J Respir Crit Care Med. 2019:rccm.201903-0624OC. doi:10.1164/rccm.201903-0624OC.
   PubMed Web of Science ®Google Scholar
• TuohyMM, RemundKF, HilfikerR, MurphyDT, MurrayJG, EganJJ. Endobronchial valve deployment in severe α-1 antitrypsin deficiency emphysema: a case series. Clin Respir J. 2013;7(1):45–52. doi:10.1111/j.1752-699X.2012.00280.x22236390
   PubMed Web of Science ®Google Scholar
• HopkinsonNS, S VK, TomaTP, et al. Atelectasis and survival after bronchoscopic lung volume reduction for COPD. Eur Respir J. 2011;37(6):1346–1351. doi:10.1183/09031936.0010011020947683
   PubMed Web of Science ®Google Scholar
• GarnerJ, S VK, TomaTP, et al. Survival after endobronchial valve placement for emphysema: a 10-year follow-up study. Am J Respir Crit Care Med. 2016;194(4):519–521. doi:10.1164/rccm.201604-0852LE27525462
   PubMed Web of Science ®Google Scholar
• GompelmannD, BenjaminN, BischoffE, et al. Survival after endoscopic valve therapy in patients with severe emphysema. Respiration. 2019;97(2):145–152. doi:10.1159/00049227430227420
   PubMed Web of Science ®Google Scholar
• PutchaN, HanMK, MartinezCH, et al. Comorbidities of COPD have a major impact on clinical outcomes, particularly in African Americans. Chronic Obstr Pulm Dis J COPD Found. 2014;1(1):105. doi:10.15326/JCOPDF.1.1.2014.0112
   PubMedGoogle Scholar
• TriestFJJ, FranssenFME, SpruitMA, GroenenMTJ, WoutersEFM, VanfleterenLEGW. Poor agreement between chart-based and objectively identified comorbidities of COPD. Eur Respir J. 2015;46(5):1492–1495. doi:10.1183/13993003.00667-201526341984
   PubMed Web of Science ®Google Scholar
• KosterTD, SlebosD-J. The fissure: interlobar collateral ventilation and implications for endoscopic therapy in emphysema. Int J Chron Obstruct Pulmon Dis. 2016;11:765–773. doi:10.2147/COPD.S10380727110109
   PubMed Web of Science ®Google Scholar
• CrinerGJ, DelageA, VoelkerK, et al. Improving lung function in severe heterogenous emphysema with the spiration® valve system (EMPROVE): a multicenter, open-label, randomized, controlled trial. Am J Respir Crit Care Med. 2019:rccm.201902-0383OC. doi:10.1164/rccm.201902-0383OC.
   Web of Science ®Google Scholar
• TendaED, RidgeCA, ShenM, YangG-Z, ShahPL. Role of quantitative computed tomographic scan analysis in lung volume reduction for emphysema. Respiration. 2019;98(1):1–9. doi:10.1159/00049894931170716
   PubMed Web of Science ®Google Scholar
• CelliBR, CoteCG, MarinJM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(10):1005–1012. doi:10.1056/NEJMoa02132214999112
   PubMed Web of Science ®Google Scholar
• PietzschJB, BuscaR, RottC, et al. Adoption patterns of bronchoscopic lung volume reduction procedures in germany and predicted procedure volumes for other European countries. Respiration. 2019;97(1):34–41. doi:10.1159/00049167730121662
   PubMed Web of Science ®Google Scholar